相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A network map of discoidin domain receptor 1(DDR1)-mediated signaling in pathological conditions
Shobha Dagamajalu et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2023)
DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6
Xiaochao Zhang et al.
ONCOGENE (2022)
KIT as a master regulator of the mast cell lineage
Mindy Tsai et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Discoidin domain receptor 1 regulates ErbB2/ErbB3 signaling in mammary epithelial cells
Andres Martin Toscani et al.
FEBS LETTERS (2022)
Discoidin domain receptors orchestrate cancer progression: A focus on cancer therapies
Yuan Gao et al.
CANCER SCIENCE (2021)
Complex roles of discoidin domain receptor tyrosine kinases in cancer
V. Mehta et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
An updated review of the treatment landscape for advanced gastrointestinal stromal tumors
Shreyaskumar R. Patel et al.
CANCER (2021)
The Yin and Yang of Discoidin Domain Receptors (DDRs): Implications in Tumor Growth and Metastasis Development
Sandra Majo et al.
CANCERS (2021)
Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors
Toshirou Nishida et al.
CANCERS (2021)
Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS)
Jiang Du et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Loss of PI3 kinase association improves the sensitivity of secondary mutation of KIT to Imatinib
Guangrong Zhu et al.
CELL AND BIOSCIENCE (2020)
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Jean-Yves Blay et al.
LANCET ONCOLOGY (2020)
Interaction of Discoidin Domain Receptor 1 with a 14-3-3-Beclin-1-Akt1 Complex Modulates Glioblastoma Therapy Sensitivity
Anne Vehlow et al.
CELL REPORTS (2019)
Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines
Reza Azizi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Inhibition of DDR1-BCR signalling by nilotinib asanew therapeutic strategy for metastatic colorectal cancer
Maya Jeitany et al.
EMBO MOLECULAR MEDICINE (2018)
miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors
Wen-Kuan Huang et al.
EXPERIMENTAL CELL RESEARCH (2018)
Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance
Jie Cao et al.
MOLECULAR CANCER (2018)
CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance
Brittni M. Foster et al.
BIOMEDICINES (2018)
Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma
Kristina Y. Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors
Y. Obata et al.
ONCOGENE (2017)
Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor
Benedikt Bosbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells
Veronica Vella et al.
ONCOTARGET (2017)
Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies
Kjetil Soreide et al.
CANCER EPIDEMIOLOGY (2016)
Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination
Junji Kurashige et al.
SCIENTIFIC REPORTS (2016)
Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma
Jinke Xu et al.
CANCER BIOLOGY & THERAPY (2014)
Discoidin domain receptor 1 controls linear invadosome formation via a Cdc42-Tuba pathway
Amelie Juin et al.
JOURNAL OF CELL BIOLOGY (2014)
Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia
Tingting Ren et al.
JOURNAL OF PATHOLOGY (2014)
Discoidin Domain Receptors: Unique Receptor Tyrosine Kinases in Collagen-mediated Signaling
Hsueh-Liang Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
George D. Demetri et al.
LANCET (2013)
The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis
Kun Zhang et al.
NATURE CELL BIOLOGY (2013)
Discoidin domain receptor tyrosine kinases: new players in cancer progression
Rajeshwari R. Valiathan et al.
CANCER AND METASTASIS REVIEWS (2012)
Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis
Karmele Valencia et al.
CLINICAL CANCER RESEARCH (2012)
Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs
J. F. Emile et al.
MEDICAL ONCOLOGY (2012)
STEM CELL FACTOR RECEPTOR/c-KIT: FROM BASIC SCIENCE TO CLINICAL IMPLICATIONS
Johan Lennartsson et al.
PHYSIOLOGICAL REVIEWS (2012)
Mutations in the DDR2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer
Peter S. Hammerman et al.
CANCER DISCOVERY (2011)
Mutations in gastrointestinal stromal tumours - a population-based study from Northern Norway
Sonja E. Steigen et al.
APMIS (2007)
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
George D. Demetri et al.
LANCET (2006)
Molecular correlates of imatinib resistance in gastrointestinal stromal tumors
Michael C. Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation
CR Antonescu et al.
CLINICAL CANCER RESEARCH (2005)
Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors
HJ Kang et al.
ONCOGENE (2005)
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
M Debiec-Rychter et al.
GASTROENTEROLOGY (2005)
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
LL Chen et al.
CANCER RESEARCH (2004)
Overexpression of the cell adhesion molecules DDR1, claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer
VA Heinzelmann-Schwarz et al.
CLINICAL CANCER RESEARCH (2004)
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Consistent and selective expression of the discoidin domain receptor-1 tyrosine kinase in human brain tumors
HL Weiner et al.
NEUROSURGERY (2000)
分享论文
